|
|
Trasylol - News Articles
-
-
There has been no action since two of the attorneys for five plaintiffs suing Bayer Corp. and two of its pharmaceutical arms over the drug Trasylol filed to bow out of the suit last September. No hearing date on the withdrawal motion has been set as yet in the suit filed by plaintiffs Don Juan Brown, Wayne Mosley, Jean Snyder, and Glendon Warner III who ...
-
-
Before its withdrawal from the US market, aprotinin (Bayer Corporation, West Haven, Conn) was used (2-MKIU bolus and 0.5-MKIU/h infusion until bleeding cessation). Subsequently, -aminocaproic acid was administered as a 10-g bolus followed by a 1-g/h ...
-
-
Do not use ARTISS in individuals with a known hypersensitivity to aprotinin and/or hypersensitivity to any of the active substance or excipients. Hypersensitivity or allergic/anaphylactoid reactions may occur with the use of ARTISS. Symptoms associated with allergic anaphylactic reactions include: flush, urticaria, pruritus, nausea, drop in blood pressure, tachycardia or bradycardia, dyspnea, ...
-
-
The risks of aprotinin outweigh the benefits; therefore, these drugs are not indicated for routine blood conservation. Use of blood derivatives may facilitate blood management (eg, plasma transfusion) in patients with serious bleeding who have multiple ...
-
-
Two small trials of aprotinin, which was withdrawn in May 2008 from world markets because of safety concerns, yielded no reliable data. Further trials to determine the effects of TXA on patients with isolated traumatic brain injury are needed, the researchers concluded. LATEST PRACTICE NEWS Drug Insurance Coverage Not a Factor in Diabetes Control Torn Meniscus Surgery Rate ...
-
-
intraoperative transfusion, and use of potentially nephrotoxic medications (eg, hydroxyethyl starches and aprotinin), may also play a role. ...
-
-
Neonates undergoing heart surgery had fewer bleeding issues with aprotinin (Trasylol) -- a drug long off the market because of adverse events in adults -- than with replacement products considered safer, researchers reported. A study of almost 500 babies found that neonates received ...
-
-
Wegen des Medikaments Trasylol, das bei Herz-Operationen eingesetzt wird, haben bis 2010 rund 1600 Patienten den Konzern in den USA verklagt. Sie werfen ihm vor, er habe nicht genug davor gewarnt, dass das Mittel zu Nierenversagen oder zum Tod führen ...
-
-
Trasylol (Bayer) Utilisé pour réduire les hémorragies en chirurgie cardiaque, il augmente significativement les risques d'insuffisance cardiaque et ...
-
-
The withdrawal of Trasylol is a notable setback for the company, especially following the withdrawal of Baycol/Lipobay around six years earlier. Both products managed to reach the market despite safety issues that subsequently led to withdrawal. This has led to ...
-
-
the legal newspaper of record for Palm Beach, Broward and Miami-Dade for his work on the national steering committee for Trasylol litigation. The four name partners have more than 100 years’ collective experience. Best Lawyers, the oldest and most respected peer-review ...
-
-
Short of surgery, other treatment options for Achilles tendinopathy include standard painkillers, injections of medications like aprotinin (which inhibits an enzyme that breaks down collagen), and injections of platelet-rich plasma into the injured joint. But whether any of ...
-
-
Aprotinin was removed from the market in 2007, because of US Food and Drug Administration concerns over a 50% greater risk in AKI, and higher 30-day mortality, said Dr. Brown. For the study, researchers analysed data from 2,333 patients who received epsilon-aminocaproic acid and from ...
-
-
Incubation with aprotinin, a Kunitz-type serine protease inhibitor that blocks the activity of endogenous CAPs, decreased Isc by 27.6% and 54% in control and CF HNEC, respectively. In control and CF HNEC pretreated with aprotinin, hNE did significantly stimulate Isc, an effect ...
-
-
Capasso G, Testa V, Maffulli N, Bifulco G: Aprotinin, corticosteroids and normosaline in the management of patellar tendinopathy in athletes: A prospective ...
-
-
So wurden beispielsweise der Cholesterin-Senker Lipobay, das Rheumamittel Vioxx und der Blutstiller Trasylol wegen tödlicher Nebenwirkungen vom Markt ...
-
-
And Bayer is slowly working its way through several thousand Trasylol lawsuits, having settled approximately 200 of 2000 cases that allege that the drug, Â which was designed to control bleeding during heart surgery, has caused serious adverse events such as kidney failure . ...
-
-
Washington, DC: Bayer AG has agreed to settle 200 of 2000 lawsuits filed over allegations that their drug, Trasylol, which was meant to control bleeding during heart surgery, has caused injuries to patients including kidney failure. The various cases are being represented by different ...
-
-
???, ????? ??????? ??????? 150 ???????? ????? ???????????? Trasylol ™ /???????? ™ (?????????). ????????, ????????????? ??? ???????? ???????????? ? ????????? ...
-
-
The National Law Journal
Bayer is slowly but surely settling lawsuits over its bleeding drug Trasylol. The company has agreed to settlement deals in about 200 of 2000 pending cases, ...
Pages:
1
2
3
4
Next
|
|
